Ranitidine Hydrochloride
Who holds supplier records for Ranitidine Hydrochloride? 6 organisations hold a current record for Ranitidine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5) and Spain (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ranitidine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ranitidine-hydrochloride
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ranitidine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 12166, 20127 · latest filing Jan 2007
- ORCHEV PHARMA PVT LTDIndiaCEPActive DMF 25851 · latest filing Feb 2012
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 17542, 18129, 31575 +1 · latest filing Mar 2017
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainActive DMF 10273, 8288 · latest filing May 1993
- SARACA LABORATORIES LTDIndiaCEP Company GMP cert on recordInactive DMF 17698 · latest filing Sept 2004
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordInactive DMF 15529, 14468 · latest filing Jul 2001
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Ranitidine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 19 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ORCHEV PHARMA PRIVATE LIMITED Rajkot | IN | CEP 2007-320 - Rev 04 Ranitidine hydrochloride, Crystalline powder grade and D.C. grade | Jun 2025 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2001-228 - Rev 11 Ranitidine hydrochloride, Form II and Form II (DC Grade) | Mar 2024 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2017-068 - Rev 03 Ranitidine hydrochloride | Mar 2024 | — |
| SARACA LABORATORIES LIMITED Gaddapotharam Village | IN | R1-CEP 2004-057 - Rev 08 Ranitidine hydrochloride | Oct 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (14)
Organisations whose Type II DMFs for Ranitidine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 14 historical records
- India · Inactive DMF 12552, 19500 · filed May 2006
- FARCHEMIA SRLInactive DMF 15676 · filed Oct 2001
- India · Inactive DMF 15141, 12532 · filed Nov 2000
- SHASUN CHEMICALS AND DRUGS LTDInactive DMF 12665 · filed Sept 1997
- India · Inactive DMF 12207 · filed Nov 1996
- Argentina · Inactive DMF 11543 · filed Jun 1995
- BOEHRINGER INGELHEIM CHEMICALS INCInactive DMF 11480 · filed Apr 1995
- SIGNA SA DE CVInactive DMF 10998 · filed Aug 1994
- Canada · Inactive DMF 10885 · filed Apr 1994
- CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTDInactive DMF 10682 · filed Dec 1993
- RANBAXY LABORATORIES LTDInactive DMF 10516 · filed Oct 1993
- PHARMAGLOBE LABORATORIES LTDInactive DMF 8953 · filed Jan 1991
- Spain · Inactive DMF 8494 · filed Mar 1990
- SHANGHAI NO 6 PHARMACEUTICAL FACTORYInactive DMF 7528 · filed Jun 1988
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ranitidine Hydrochloride is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used to treat and prevent ulcers in the stomach and intestines, and conditions such as gastroesophageal reflux disease.
Chemical identity
- IUPAC name
- 1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
- Canonical SMILES
- CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
- InChIKey
- VMXUWOKSQNHOCA-UHFFFAOYSA-N
- Synonyms
- Zantac API, Gastrosedol, Achedos, Duractin, Istomar, Microtid, Ptinolin, Quicran, Radinat, Ranidine, Raniogas, Ranisen
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Histamine-2 Receptor Antagonist
- Mechanism of action
- Histamine H2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ranitidine Hydrochloride?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Ranitidine Hydrochloride: Dr. Reddy's Laboratories Ltd. (India), ORCHEV PHARMA PVT LTD (India), SMS Pharmaceuticals limited (India), UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (Spain), SARACA LABORATORIES LTD (India) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ranitidine Hydrochloride Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 12166, 20127), ORCHEV PHARMA PVT LTD (DMF 25851), SMS Pharmaceuticals limited (DMF 17542, 18129) and UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (DMF 10273, 8288). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ranitidine Hydrochloride records mean?
14 organisations have only inactive Type II DMFs for Ranitidine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ranitidine Hydrochloride have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Ranitidine Hydrochloride on the EDQM register, including ORCHEV PHARMA PRIVATE LIMITED Rajkot (IN), SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN), SMS PHARMACEUTICALS LIMITED Hyderabad (IN) and SARACA LABORATORIES LIMITED Gaddapotharam Village (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ranitidine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ranitidine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.